Moberg Pharma AB (publ) (STO:MOB)
9.48
+0.11 (1.12%)
Feb 10, 2026, 5:29 PM CET
Moberg Pharma AB Market Cap
Moberg Pharma AB has a market cap or net worth of 445.57 million as of February 10, 2026. Its market cap has decreased by -4.14% in one year.
Market Cap
445.57M
Enterprise Value
212.32M
Revenue
12.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.48
Market Cap Chart
Since May 26, 2011, Moberg Pharma AB's market cap has increased from 260.60M to 445.57M, an increase of 70.98%. That is a compound annual growth rate of 3.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 440.63M | -8.71% |
| Dec 30, 2025 | 482.70M | 1.65% |
| Dec 30, 2024 | 474.87M | 11.73% |
| Dec 29, 2023 | 425.01M | 86.42% |
| Dec 30, 2022 | 227.99M | -3.61% |
| Dec 30, 2021 | 236.53M | 65.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 2.10B |
| EQL Pharma AB | 1.82B |
| Orexo AB | 976.50M |
| Cinclus Pharma Holding AB | 784.63M |
| Dicot Pharma AB | 661.07M |
| Nanexa AB | 592.66M |
| Enzymatica AB | 449.06M |
| Klaria Pharma Holding AB (publ.) | 243.02M |